These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1020054)

  • 1. Myocardial injury induced by a single dose of adriamycin: an electron microscopic study.
    Lambertenghi-Deliliers G; Zanon PL; Pozzoli EF; Bellini O
    Tumori; 1976; 62(5):517-28. PubMed ID: 1020054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural alterations of atrial myocardium induced by adriamycin in chronically treated animals.
    Lambertenghi-Deliliers G; Zanon PL; Pozzoli EF; Bellini O; Praga C
    Tumori; 1978 Feb; 64(1):15-24. PubMed ID: 565963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of adriamycin on ultrastructure of nucleoli in the heart and liver cells of the rat.
    Merski JA; Daskal I; Busch H
    Cancer Res; 1976 May; 36(5):1580-4. PubMed ID: 1268820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Pathol; 1980 Apr; 99(1):13-42. PubMed ID: 7361854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration.
    Rahman A; More N; Schein PS
    Cancer Res; 1982 May; 42(5):1817-25. PubMed ID: 7066898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human myocardial morphologic and functional changes in the first 24 hours after doxorubicin administration.
    Unverferth DV; Magorien RD; Unverferth BP; Talley RL; Balcerzak SP; Baba N
    Cancer Treat Rep; 1981; 65(11-12):1093-7. PubMed ID: 7296554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function of myocardial mitochondria in the adriamycin-induced cardiomyopathy of rabbits.
    Bier CC; Jaenke RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1091-4. PubMed ID: 1003544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of adriamycin-induced nucleolar segregation in skeletal muscle, cardiac muscle, and liver cells.
    Merski J; Daskal Y; Busch H
    Cancer Treat Rep; 1978 May; 62(5):771-8. PubMed ID: 657162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear and nucleolar damage in adriamycin-induced toxicity to rat sensory ganglion cells.
    Cavanagh JB; Tomiwa K; Munro PM
    Neuropathol Appl Neurobiol; 1987; 13(1):23-38. PubMed ID: 2437486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early changes in human myocardial nuclei after doxorubicin.
    Unverferth BJ; Magorien RD; Balcerzak SP; Leier CV; Unverferth DV
    Cancer; 1983 Jul; 52(2):215-21. PubMed ID: 6861067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity.
    Rosenoff SH; Olson HM; Young DM; Bostick F; Young RC
    J Natl Cancer Inst; 1975 Jul; 55(1):191-4. PubMed ID: 1159813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.
    Jackson JA; Reeves JP; Muntz KH; Kruk D; Prough RA; Willerson JT; Buja LM
    Am J Pathol; 1984 Oct; 117(1):140-53. PubMed ID: 6486242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural changes produced in cultured, adriamycin-treated myocardial cells.
    Necco A; Dasdia T; Cozzi S; Ferraguti M
    Tumori; 1976; 62(5):537-43. PubMed ID: 1020055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine.
    Wakasugi S; Wada A; Hasegawa Y; Nakano S; Shibata N
    J Nucl Med; 1992 Feb; 33(2):208-14. PubMed ID: 1732442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
    Ferrans VJ
    Cancer Treat Rep; 1978 Jun; 62(6):955-61. PubMed ID: 352510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar alterations of myocardial cells and glomerular epithelial cells in rats after a single administration of adriamycin.
    Hayashi Y; Imazawa T; Kokubo T; Kurokawa Y; Takahashi M
    Toxicol Lett; 1984 Jan; 20(1):105-10. PubMed ID: 6695388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin.
    Kushner JP; Hansen VL; Hammar SP
    Cancer; 1975 Nov; 36(5):1577-84. PubMed ID: 172214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adriamycin induced chronic cardiotoxicity: a morphological ultrastructural study on ventricular myocardium and conducting system of rabbit heart (author's transl)].
    Gandolfi A
    Ateneo Parmense Acta Biomed; 1976; 47(1):69-78. PubMed ID: 1016274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.